W.R. Berkley Corp’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

W.R. Berkley Corp’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,119,638	Closed	-$12.1M	–	247
2023 Q3	$12.1M	Buy	1,119,638 +522,007	+87%	+$5.6M	0.79%	22
2023 Q2	$6.36M	Sell	597,631 -63,910	-10%	-$672K	0.38%	40
2023 Q1	$6.91M	Buy	661,541 +387,681	+142%	+$4.02M	0.44%	41
2022 Q4	$2.8M	Hold	273,860	–	–	0.15%	107
2022 Q3	$2.75M	Hold	273,860	–	–	0.13%	148
2022 Q2	$2.72M	Hold	273,860	–	–	0.14%	137
2022 Q1	$2.71M	Buy	+273,860	New	+$2.7M	0.14%	146

W.R. Berkley Corp's BIOS Position: Q4 2023 in Review

W.R. Berkley Corp sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 1,119,638 shares — an estimated $12.1M sold.

W.R. Berkley Corp first reported a position in BIOS in Q1 2022 and held it in 7 quarters. The position peaked at $12.1M in Q3 2023. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

W.R. Berkley Corp reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
W.R. Berkley Corp sold 1,119,638 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $12.1M.
W.R. Berkley Corp first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 7 quarters.
W.R. Berkley Corp's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $12.1M in Q3 2023.
0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on W.R. Berkley Corp's 13F filing for Q4 2023, filed 14 Feb 2024.